Quick answer: For most oncology practices, the answer is buy. A purpose-built fax triage vendor already solves the hard parts — accurate document classification, reliable patient matching, EHR integration, and HIPAA-grade handling — that an in-house script can't reach without a standing engineering team. Building only makes sense for the rare oncology group with real technical resources and a workflow no vendor fits. For everyone else, buying gets you to value in weeks instead of quarters and hands the ongoing maintenance to a team whose full-time job is keeping the models accurate.
What "build" actually means for an oncology practice
Before you can weigh build against buy, you have to be honest about what "build" involves. It isn't buying an off-the-shelf OCR tool and pointing it at the fax inbox. A working fax triage system for an oncology office has to do five things reliably: classify each inbound document by type, extract the right structured fields, match the document to the correct patient chart, file it into the EHR with metadata, and route follow-up tasks to the right worklist.
Each of those is a real engineering problem. Classification has to handle pathology reports, molecular panels, imaging, referrals, and payer letters that arrive in dozens of formats from different senders. Extraction has to pull a medical record number whether it sits in a form box, a paragraph, or a margin scrawl. Patient matching has to resolve duplicate charts and name variations without attaching a biopsy result to the wrong person.
"Build" means owning all of that — the models, the integrations, and the accuracy — indefinitely. For an oncology practice whose core competency is treating cancer, that's a large commitment to a problem that isn't your business.
The true cost of building fax triage in-house
The build estimate that gets pitched internally almost always understates the real number, because it counts the first version and ignores the rest.
A credible in-house build requires machine learning or data engineering talent, not just a developer who can wire up an OCR API. Healthcare document AI is a specialty — the 2025 CAQH Index notes that just 25% of provider organizations have adopted AI tools in administrative workflows at all, and most of those bought rather than built, because the talent to build it is scarce and expensive.
Then there's maintenance, which is where homegrown systems quietly die. Referring practices change their templates. Payers redesign their authorization letters. A new lab joins your referral network with a format the classifier has never seen. Each change degrades accuracy, and someone has to retrain the model and re-test it. That's not a one-time project cost — it's a permanent line item.
Add the opportunity cost. Every engineering hour spent on fax classification is an hour not spent on something only your practice can do. For a back-office function that vendors have already solved, that's an expensive way to reinvent a wheel.
What you're really buying when you buy
Buying fax triage isn't just renting software — it's renting an accuracy guarantee and a maintenance team.
A purpose-built vendor has already trained its models on millions of healthcare documents, so it reaches production accuracy on day one instead of after months of tuning. Strong systems classify 30 or more document types at 90% or higher accuracy and match patients straight-through 85 to 95% of the time. That baseline took the vendor years and a dedicated team to build, and you get it immediately.
You're also buying the integration work. A vendor that has shipped on athenahealth, Epic, or your oncology-specific EHR has already solved the write-back path — the HL7 messages, the FHIR calls, the interface-engine configuration, the desktop-automation bridge for closed systems. Reproducing that in-house is often the single largest hidden cost of building.
And you're buying the maintenance the homegrown route can't sustain. When a payer redesigns its authorization letter, keeping the model accurate is the vendor's problem, not your front office's. That's the part of "buy" that's easy to undervalue until you've watched an internal tool slowly stop working.
Where build-versus-buy actually tips
Build isn't always wrong — it's just rarely right for an oncology practice. A short framework cuts through it.
- Volume and complexity. Under 30 inbound faxes a day, even buying can be hard to justify on labor alone, and building never pencils out. Above 60 a day, the automation matters — and the case for buying a proven system over building one strengthens, because the cost of inaccuracy scales with volume.
- Technical resources. If you don't already employ machine learning engineers, build is off the table; you'd be hiring a team to maintain one internal tool. Most oncology groups, even large ones, don't have that bench.
- Workflow fit. Build only earns consideration when your workflow is genuinely unlike anything a vendor offers. For inbound fax triage, that's almost never the case — the problem is common across specialties, which is exactly why vendors exist for it.
- Time to value. Buying reaches production in weeks. Building reaches a first version in quarters and steady accuracy later. For a practice drowning now, that gap is decisive.
If you walk through those four and still land on build, you likely have a rare combination of scale and engineering depth. For everyone else, buy is the rational answer.
The integration and compliance risk of DIY
The risk side of building is where oncology practices get caught, because the failure modes aren't visible until they bite.
Compliance is the first. Any system that reads inbound faxes handles protected health information, which means HIPAA Security Rule safeguards, encryption at rest and in transit, audit logging on every PHI access, and a defensible breach-response process. A purpose-built vendor signs a Business Associate Agreement and typically carries HITRUST CSF certification and SOC 2 Type II audits. A homegrown tool puts all of that — and the liability — on your practice.
Integration is the second. EHR write-back is brittle. An API changes, an interface engine update breaks a feed, a desktop-automation script stops matching the EHR's screen after a version upgrade. A vendor monitors and fixes those breaks as part of the subscription. An internal build leaves your team debugging a filing pipeline while pathology reports pile up in a queue — and in oncology, a stalled filing pipeline isn't just an IT ticket, it's delayed results on real patients.
Accuracy drift is the third. Without a team actively retraining models, a homegrown classifier's accuracy decays as document formats evolve. The tool that worked at launch quietly becomes the tool staff stop trusting.
How a platform changes the build-versus-buy math
The build-versus-buy question usually gets framed as one workflow, but most oncology practices end up automating more than fax over time — referral intake, prior authorization, denial management. That changes the calculation.
If you build, each new workflow is a fresh engineering project with its own models, integrations, and maintenance. The cost compounds. If you buy a single-purpose fax tool, you solve fax but face the same buy-or-build decision again for the next workflow, and another vendor to manage.
A connected platform changes that. Honey Health's Fax Triage agent files inbound documents and routes the ones that need action into the agents that own referral intake, prior authorization, and denial management — so a faxed referral moves from filing into a booked appointment, and a prior auth decision lands in the workflow that handles the next step. You buy once and extend across the back office instead of rebuilding for each function. For a mid-to-large oncology group planning to automate beyond fax, that turns a series of build-versus-buy decisions into a single one.
The honest caveat: if fax triage is genuinely the only thing you'll ever automate, a narrower point solution may be a tighter fit on price. But that's rarely the real trajectory once a practice sees the first workflow pay off.
Frequently asked questions
Is it cheaper to build or buy fax triage software for an oncology practice?
Buying is almost always cheaper once you count the full cost of building — machine learning talent, EHR integration work, and permanent maintenance as document formats change. A homegrown tool's sticker price ignores the ongoing engineering required to keep accuracy from decaying, which is where most internal builds quietly fail.
When does building fax triage in-house make sense?
Rarely, and only for oncology groups that already employ machine learning engineers, run very high fax volume, and have a workflow no vendor fits. For inbound fax triage specifically — a problem common across specialties — that combination almost never holds, which is why purpose-built vendors exist for it.
What are the hidden costs of building fax triage automation?
The hidden costs are maintenance and compliance. Models degrade as referring practices and payers change document formats, so someone must retrain them continuously. And the system handles PHI, so your practice owns the HIPAA safeguards, audit logging, and breach liability a vendor would otherwise carry under a Business Associate Agreement.
How long does it take to buy versus build fax triage?
Buying reaches production in about 2 to 4 weeks for cloud EHRs and 6 to 12 weeks for Epic or on-premise systems, mostly integration time. Building reaches a first version in quarters and dependable accuracy later, after model tuning. For a practice that needs relief now, that timeline gap usually settles the decision.
Can we start by buying and build later if needed?
Yes, and that's the lower-risk path. Buying a proven system now gets you immediate value and a real baseline for accuracy and ROI. If you later find a genuinely unique workflow no vendor serves, you'll have data and experience to scope a build — rather than committing engineering resources to a problem vendors have already solved.
